UNSPSC 41202069: Varicella-zoster virus serological reagents

In this classification, Varicella-zoster virus serological reagents are devices used in test to identify specific Varicella-zoster virus antibodies in serum. US FDA regulates Varicella-zoster virus serological reagents under 21 CFR 866.3900 and under FDA product code GQW.

UNSPSC 41202069 Varicella-zoster virus serological reagents (Commodity) encompasses diagnostic testing supplies and reagents for infectious disease screening, though recent state and local activity under this code shows minimal direct procurement aligned with the varicella-zoster scope. Instead, the recent opportunities posted under this code focus heavily on HIV, syphilis, and general drug-testing supplies used by public health departments, criminal justice agencies, and health care services. State and local buyers—including health departments, correctional supervision departments, county health services, and city public health programs—solicit these reagents and kits through competitive bidding (IFB, RFP) and emergency procurement vehicles. The work typically includes establishing annual or multi-year supply contracts for diagnostic test kits, reagent consumables, calibrators, controls, and ancillary testing materials compatible with existing laboratory analyzer systems; vendors must often meet CLIA, SAMHSA, or CAP certification requirements and deliver items without surcharges for shipping or installation.

Recent activity concentrates in Texas and Illinois. The Illinois Department of Public Health has conducted multiple emergency procurements for Abbott HIV and syphilis reagents (May and August 2026, totaling $38,079.50 and $900,000 respectively across contract amendments) to maintain analyzer operations and CLIA compliance at its Carbondale Laboratory. Texas buyers include Collin County Community Supervision and Corrections Department (RFP 2026-327, due July 23, 2026, $600,000 estimated value for offender drug-testing services including immunoassay screening and LC/MS/MS confirmation), Collin County Health Care Services (IFB 2025-166, originally due October 2, 2025, $70,000 estimated annual value for comprehensive laboratory services including HIV testing), and Gwinnett County, Georgia (RFP PE77023NONST2027000000764, due October 14, 2026, for drug-testing supplies compatible with an existing analyzer). The City of Austin posted two separate HIV test kit procurements (IFB 9100 AAM1023, July 17, 2026, and rebid IFB 9100 AAM1023REBID, September 3, 2026) seeking Abbott Determine rapid HIV test kits at approximately 375 units annually. Contract values and volumes typically range from $38,000 to $900,000 annually, with multi-year initial terms and renewal options common.